By continuing to browse our site you agree to our Privacy & Cookie Policy. > Privacy & Cookie Policy I Agree

14 Sep 2022 --- Lallemand Health Solutions’ two probiotic strains, B.infantis Rosell-33 and B.infantis Rosell-71, are to receive recognition from Canada Health Authority for the potential to develop similar microflora for infants as breast milk. Additionally, Nestlé unveils new findings on infant formula blends, emphasizing the efficacy of myelination levels.

“For infants that are not breastfed, commercial probiotics in infant formula or supplements can provide the necessary bacteria required to help develop their immune system in a similar way as a breastfed infant, providing an equitable start to life,” Solange Henoud, VP at regulatory and compliance for Lallemand Health Nutrition, tells NutritionInsight.

Lallemand highlights this as the “first time a health authority recognizes probiotic strains” for this purpose, noting that the two strains “help maintain a baby-like microflora in infants (for formula-fed infants), and to balance formula-fed baby’s microflora similar to breastfed infants.”

“The science and work carefully achieved during the past years assessing the safety and beneficial impact of these strains on a baby-specific microflora continue to receive official acknowledgments. This is a huge step in demonstrating that our probiotics can contribute to supporting normal gut and immune maturation in early life,” Henoud adds.

Probiotics, breastmilk and microbiomeBoth companies stress innovation in alternatives as crucial for infants not able to breastfeed. Nestlé has also unveiled scientific findings for infant formula ingredients. While stressing breastmilk to be the ideal nutrition for babies and supporting the World Health Organization’s (WHO) recommendations of exclusive breastfeeding for the first six months of life, Nestlé underscores the importance of alternatives for infants unable to breastfeed. 

“Breast milk contains important nutrients and bioactives relevant to brain development. With this new research, we have discovered a nutrient blend that can provide infants that cannot be breastfed with an alternative to support myelination”, says Ryan Carvalho, global head of R&D and chief medical officer at Nestlé Nutrition.

“When looking at two groups of babies, one breastfed, one formula-fed, there will be noticeable differences in the gut microbial composition. The microbiome of formula-fed babies shifts toward an ‘adult-like’ microbiota at a quicker rate, with higher overall bacterial diversity. In addition, in exclusively formula-fed babies, a greater prevalence of E. coli, C. difficile, B. fragilis and Lactobacilli species have been observed to colonize the gut,” Henoud adds.

The two strains have previously been recognized as GRAS (Generally Recognized as Safe).

Henoud adds that the US Food and Drug Administration previously endorsed the usage of these specific strains in infants’ formula is GRAS.

“An achievement that was followed by several other health authorities, under different jurisdictions, such as the listing by the Chinese authorities and Canadian Food Directorate as a new infant formula ingredient – needless to say that these lists are very narrow and only few specific strains are permitted for such use.” 

Industry moving forward Henoud highlights the industry’s interest in developing nutritious infant formulas with “exclusive ingredients” that meet the requirements. 

“Given the limited numbers of recognized strains suitable for infant formula, probiotics can be a powerful differentiating feature. As the industry and parents increasingly understand the role of the microbiota in early life to promote a timely gut and immune maturation, the shift will happen.”

Nestlé recently said it would stop global marketing for infant formulas up to six months of age to follow the advice of the WHO. 

This feature is provided by FoodIngredientsFirst’s sister website, NutritionInsight.

To contact our editorial team please email us at editorial@cnsmedia.com

With company roots dating back to the end of the nineteenth century, Lallemand has an established history and an exceptional reputation as a global leader in microbial fermentation using yeast and bacteria.

Pioneer in the probiotic industry, with over 85 years of know-how, Lallemand Health Solutions is one of Lallemand’s business unit, and is strictly dedicated to probiotics for human health. Lallemand Health Solutions is a vertically integrated, lab to shelf, probiotic manufacturer specialized in the research, development and manufacturing of ready-to-market and custom probiotic formulations. Its products target specific populations and health segments including gut health, immune health, mental health, women’s health, skin health, oral health, metabolic health, and sport. Probiotics are produced in cutting-edge plants, all certified to the highest quality. With over 40 proprietary strains, more than 600 probiotic formulas marketed in over 60 countries across five continents, Lallemand Health Solutions probiotics products reach millions of patients and enhance lives in countless ways.

The Rosell® Institute for Microbiome and Probiotics by Lallemand

Lallemand Health Solutions’ research and development center is the Rosell® Institute for Microbiome and Probiotics. The Rosell® Institute applies leading-edge technologies and innovative scientific approaches to the improvement of human health through understanding the interaction between people and their functional microbiome. The research team has issued over 340 publications including in vitro, in vivo and 160 clinical studies working with industry leaders and scientific experts. Cooperation spells success!

Find out more at lallemand-health-solutions.com

For more information, please contact healthsolutions@lallemand.com

Follow us on Linkedin and YouTube

No longer authorized as a food additive in the EU, titanium dioxide is officially banned across Europe, prompting more companies to innovate alternatives to what was... Read More

Kendamil and Danone are set to export infant formula products to the US which continues to struggle with shortages. Announcing Operation Fly Formula 21 and 22, the Biden... Read More

Abbott Nutrition is restarting infant formula production at its Sturgis plant, Michigan, US, after halting Similac production in February. The company estimates products... Read More

Netherlands-based WholeFiber is introducing its prebiotic WholeFiber, touted as a super prebiotic fiber source that is natural and made from dried, minimally processed... Read More

FrieslandCampina is set to introduce Biotis GOS-OP High Purity in the Asian-Pacific region (APAC), with a September launch. Its high leveled Galacto-oligosaccharides... Read More

Subscribe now to our free newsletters to stay informed with the most interesting industry news articles, actionable NPD insights and breaking news from around the world.

FoodIngredientsFirst.com is the leading international publisher on food ingredients and food product development. The platform is hosted by CNS Media BV, Arnhem, The Netherlands.